Your browser doesn't support javascript.
loading
Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis.
Wu, Yanqiao; Sreeharsha, Nagaraja; Sharma, Sanjay; Mishra, Anurag; Singh, Avinash Kumar; Gubbiyappa, Shiva Kumar.
Affiliation
  • Wu Y; Intensive Care Unit, People's Hospital of Ningjin County, Ningjin County, Shandong province 253400, China.
  • Sreeharsha N; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Sharma S; NMIMS, School of Pharmacy and Technology Management, Shirpur 425405, Maharashtra, India.
  • Mishra A; School of Pharmacy, Suresh Gyan Vihar University, Jaipur 302017, Rajasthan, India.
  • Singh AK; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi 110062, India.
  • Gubbiyappa SK; School of Pharmacy, GITAM University, Hyderabad 530045, India.
ACS Omega ; 5(10): 5334-5339, 2020 Mar 17.
Article in En | MEDLINE | ID: mdl-32201822
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Omega Year: 2020 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: ACS Omega Year: 2020 Document type: Article Affiliation country: China